| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts Presented at the 12th Panhellenic Pharmaceutical Congress
|
|
|
2005
|
30 |
1-2 |
p. 141-144
|
artikel
|
| 2 |
An overview about Biopharmaceutics in Europe
|
Aiache, Jean-Marc
|
|
2005
|
30 |
1-2 |
p. 19-27
|
artikel
|
| 3 |
Biopharmaceutical characterization of sustained release matrix tablets based on novel carbomer polymers: formulation and in vivo investigation
|
Parojčić, Jelena
|
|
2005
|
30 |
1-2 |
p. 99-104
|
artikel
|
| 4 |
[2-14C]Thymidine incorporation activity of stem cells in either tumor or cradle tissues in a normal or transplanted animals
|
Shigematsu, Akiyo
|
|
2005
|
30 |
1-2 |
p. 29-39
|
artikel
|
| 5 |
Detection of nimesulide metabolites in rat plasma and hepatic subcellular fractions by HPLC-UV/DAD and LC-MS/MS studies
|
Küçükgüzel, Ş. Güniz
|
|
2005
|
30 |
1-2 |
p. 127-134
|
artikel
|
| 6 |
Developmental pharmacology and toxicology: Biotransformation of drugs and other xenobiotics during postnatal development
|
Klinger, Wolfgang
|
|
2005
|
30 |
1-2 |
p. 3-17
|
artikel
|
| 7 |
Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs
|
Xie, Hai-Tang
|
|
2005
|
30 |
1-2 |
p. 63-67
|
artikel
|
| 8 |
Different effect of erythromycin on absorption kinetics of nimodipine in male and female rats
|
Liu, X. D.
|
|
2005
|
30 |
1-2 |
p. 69-73
|
artikel
|
| 9 |
Editorial
|
Benakis, A.
|
|
2005
|
30 |
1-2 |
p. 1-2
|
artikel
|
| 10 |
Events
|
|
|
2005
|
30 |
1-2 |
p. 137-140
|
artikel
|
| 11 |
Influence of different calcic antagonists on the Caco-2 cell monolayer integrity or “TEER, a measurement of toxicity ?”
|
Mathieu, F.
|
|
2005
|
30 |
1-2 |
p. 85-90
|
artikel
|
| 12 |
In vitro andin vivo metabolism of ethyl 4-[(2-hydroxy-1-naphthyl)azo]benzoate
|
Bekce, Banu
|
|
2005
|
30 |
1-2 |
p. 91-97
|
artikel
|
| 13 |
Letter to the Editor
|
|
|
2005
|
30 |
1-2 |
p. 47
|
artikel
|
| 14 |
Metabolism of the α-1A-adrenergic receptor antagonist, pyridine-phenylpiperazine analog (RWJ-69597), in rat, dog and human hepatic S9 factions -API-MS/MS identification of metabolites
|
Wu, W. N.
|
|
2005
|
30 |
1-2 |
p. 105-111
|
artikel
|
| 15 |
Metabolism of the new α-1A-adrenergic receptor antagonist, phthalimide-phenylpiperazine analog (RWJ-69442), in rat, dog and human hepatic S9 fractions, and in rats
|
Wu, W. N.
|
|
2005
|
30 |
1-2 |
p. 113-120
|
artikel
|
| 16 |
New Books
|
|
|
2005
|
30 |
1-2 |
p. 135-136
|
artikel
|
| 17 |
Pharmacokinetic and pharmacodynamic of irbesartan in renal hypertensive dogs under non-steady-state and steady-state conditions
|
Huang, Xiao-Hui
|
|
2005
|
30 |
1-2 |
p. 121-126
|
artikel
|
| 18 |
Statistical aspects of bioequivalence testing between two medicinal products
|
Zintzaras, E.
|
|
2005
|
30 |
1-2 |
p. 41-46
|
artikel
|
| 19 |
The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens
|
Caldwell, Gary W.
|
|
2005
|
30 |
1-2 |
p. 75-83
|
artikel
|
| 20 |
Transport of thalidomide by the human intestinal Caco-2 monolayers
|
Zhou, Shufeng
|
|
2005
|
30 |
1-2 |
p. 49-61
|
artikel
|
Tijdschrift beschrijving